SCHEMBL67119

SCHEMBL67119

c1cc2[nH]cnc2cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29602491 1.00 — —
Hydrochloric Acid SCHEMBL2308667 0.98 KDM4A (0.53) —
Bromide SCHEMBL4711523 0.98 KDM4A (0.53) —
Hydrochloric Acid SCHEMBL16162592 0.98 KDM4A (0.53) —
SCHEMBL27982384 0.98 KDM4A (0.53) —
SCHEMBL28092901 0.84 QPCT (0.44) —
SCHEMBL4048108 0.83 KDM4A (0.41) —
SCHEMBL4048111 0.83 KDM4A (0.41) —
SCHEMBL89868 0.82 — —
SCHEMBL29837279 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3361 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260060970-A1 Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance MITODICURE GMBH (DE) 2026-03-05 — — US claimed
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 — — EP claimed
CN-115925702-B Purification method of imidazo [4,5-C ] pyridine derivative and imidazo [4,5-C ] pyridine derivative 江西凌富生物科技有限公司 2025-04-25 — — CN claimed
US-20250034139-A1 AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY PHARMA CINQ, LLC 2025-01-30 — — US claimed
US-20250019373-A1 ARYL OR HETEROARYL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF KINASE-RELATED DISEASES VORONOI INC. (KR) 2025-01-16 — — US claimed
CN-119219629-A N-benzyl imidazopyridine derivative and preparation method and application thereof 中国药科大学 2024-12-31 — — CN claimed
EP-4421077-A1 ARYL OR HETEROARYL DERIVATIVE, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF KINASE-RELATED DISEASES Voronoi Inc. (KR) 2024-08-28 — — EP claimed
CN-118475578-A Aryl or heteroaryl derivatives for preventing or treating kinase-related diseases and pharmaceutical compositions containing the same as active ingredient 沃若诺伊公司 2024-08-09 — — CN claimed
EP-4405347-A1 PYRIDINE DERIVATIVES AND THEIR USE AS SODIUM CHANNEL ACTIVATORS Xenon Pharmaceuticals Inc. (CA) 2024-07-31 — — EP claimed
US-20240246905-A1 VINYL ISOCYANIDE COMPOUNDS AS ANTIBACTERIAL AGENTS UNIVERSITY OF LEICESTER (GB) 2024-07-25 — — US claimed
EP-0605434-A1 IMIDAZO (4,5-C) PYRIDINE DERIVATIVES AS PAF ANTAGONISTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1994-07-13 — — EP claimed
US-5310928-A Process for preparing biphenyltetrazole compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 1994-05-10 — — US claimed
WO-1993002080-A1 IMIDAZO (4,5-C) PYRIDINE DERIVATIVES AS PAF ANTAGONISTS BRITISH BIO-TECHNOLOGY LIMITED (GB) 1993-02-04 — — WO claimed
EP-0260613-A2 Imidazopyridine derivatives, their preparation and their use as PAF-antagonists G.D. Searle & Co. (US) 1988-03-23 — — EP claimed
US-4654350-A Gaba-agonistic imidazo(4,5-c)pyridines useful as pharmaceuticals MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1987-03-31 — — US claimed
EP-0184738-A2 Imidazole derivatives, medicaments containing these compounds, and process for their preparation Dr. Karl Thomae GmbH (DE) 1986-06-18 — — EP claimed
EP-0082369-B1 IMIDAZO (4,5-C) PYRIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION MERCK PATENT GmbH (DE) 1986-04-09 — — EP claimed
EP-0130461-A2 Imidazoles, their preparation, and medicaments containing these compounds Dr. Karl Thomae GmbH (DE) 1985-01-09 — — EP claimed
EP-0098448-A2 Imidazole derivatives, their preparation and medicines containing these compounds Dr. Karl Thomae GmbH (DE) 1984-01-18 — — EP claimed
EP-0038568-B1 SYNTHESIS OF DEAZAPURINE NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1983-07-20 — — EP claimed
Send feedback